JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2026
Arch Capital
ACGL
$32.4B
| $10.1M | ﹤0.01% |
277,892
-35,802
| -11% | -$1.22M |
2013 Q2
24 quarters
|
|
|
MDC
2027
DELISTED
M.D.C. Holdings, Inc.
MDC
| $10.1M | ﹤0.01% |
337,150
+268,336
| +390% | +$7.9M |
2013 Q2
24 quarters
|
|
2028
Blackstone Mortgage Trust
BXMT
$1.9B
| $10.1M | ﹤0.01% |
284,227
+23,185
| +9% | +$825K |
2013 Q2
24 quarters
|
|
|
CTRL
2029
DELISTED
Control4 Corporation
CTRL
| $10M | ﹤0.01% |
422,233
+415,788
| +6,451% | +$8.72M |
2017 Q3
7 quarters
|
|
|
KW
2030
DELISTED
Kennedy-Wilson Holdings
KW
| $10M | ﹤0.01% |
493,428
+289,451
| +142% | +$6.16M |
2015 Q1
17 quarters
|
|
|
OMP
2031
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
| $10M | ﹤0.01% |
459,586
+16,789
| +4% | +$338K |
2017 Q3
7 quarters
|
|
2032
iShares S&P 100 ETF
OEF
$20.9B
| $10M | ﹤0.01% |
77,640
+5,230
| +7% | +$668K |
2013 Q2
24 quarters
|
|
2033
Graham Holdings Company
GHC
$4.9B
| $10M | ﹤0.01% |
14,672
+3,427
| +30% | +$2.39M |
2013 Q2
24 quarters
|
|
2034
Fossil Group
FOSL
$430M
| $10M | ﹤0.01% |
867,892
-704,514
| -45% | -$8.65M |
2013 Q2
24 quarters
|
|
2035
Equifax
EFX
$16.9B
| $9.99M | ﹤0.01% |
75,454
-11,727
| -13% | -$1.47M |
2013 Q2
24 quarters
|
|
2036
AMERISAFE
AMSF
$437M
| $9.99M | ﹤0.01% |
160,297
+89,978
| +128% | +$5.38M |
2013 Q2
24 quarters
|
|
2037
Cars.com
CARS
$515M
| $9.97M | ﹤0.01% |
502,838
+266,245
| +113% | +$5.69M |
2017 Q2
8 quarters
|
|
2038
CALL
NovoCure
NVCR
$1.84B
| $9.92M | ﹤0.01% |
163,000
| – | – |
2018 Q3
3 quarters
|
|
2039
CONMED
CNMD
$1.37B
| $9.87M | ﹤0.01% |
115,660
-40,194
| -26% | -$3.3M |
2013 Q2
24 quarters
|
|
2040
Sterling Infrastructure
STRL
$16.9B
| $9.83M | ﹤0.01% |
736,622
-10,009
| -1% | -$129K |
2017 Q2
8 quarters
|
|
|
EVF
2041
Eaton Vance Senior Income Trust
EVF
$88.1M
| $9.82M | ﹤0.01% |
1,579,470
-332,350
| -17% | -$2.07M |
2014 Q3
19 quarters
|
|
2042
Albemarle
ALB
$12.5B
| $9.82M | ﹤0.01% |
141,236
-17,167
| -11% | -$1.27M |
2013 Q2
24 quarters
|
|
2043
Vishay Intertechnology
VSH
$5.71B
| $9.79M | ﹤0.01% |
605,421
+45,432
| +8% | +$802K |
2013 Q2
24 quarters
|
|
2044
Invesco S&P 500 Low Volatility ETF
SPLV
$7.04B
| $9.79M | ﹤0.01% |
178,784
-44,169
| -20% | -$2.37M |
2013 Q2
24 quarters
|
|
|
CBPX
2045
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $9.78M | ﹤0.01% |
382,090
-19,008
| -5% | -$478K |
2015 Q3
15 quarters
|
|
2046
Bloom Energy
BE
$86.7B
| $9.75M | ﹤0.01% |
837,885
+470,291
| +128% | +$5.77M |
2018 Q3
3 quarters
|
|
2047
Amdocs
DOX
$6.12B
| $9.75M | ﹤0.01% |
158,071
+22,576
| +17% | +$1.3M |
2013 Q2
24 quarters
|
|
2048
GDS Holdings
GDS
$6.09B
| $9.73M | ﹤0.01% |
264,912
+128,650
| +94% | +$4.69M |
2017 Q1
9 quarters
|
|
2049
PUT
Molina Healthcare
MOH
$10.1B
| $9.72M | ﹤0.01% |
+68,800
| New | +$9.42M |
2019 Q2
0 quarters
|
|
2050
PUT
Ventas
VTR
$41.9B
| $9.72M | ﹤0.01% |
140,000
+100,000
| +250% | +$6.38M |
2019 Q1
1 quarter
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.